We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Synthetic Printed Implants Prompt Spinal Regeneration in Model

By LabMedica International staff writers
Posted on 31 Jan 2019
The potential use of three-dimensional (3D) printing to produce replacement components for the repair of spinal damage was demonstrated in a rat model system.

Up to now, three-dimensional printing of central nervous system (CNS) structures has not been accomplished, possibly owing to the complexity of CNS architecture. More...
To rectify this situation, investigators at the University of California, San Diego (USA) used a three-dimensional microscale continuous projection printing method (MuCPP) to create a complex CNS structure for regenerative medicine applications in the spinal cord.

The MuCPP method enabled printing of three-dimensional biomimetic hydrogel scaffolds that were tailored to the dimensions of the rodent spinal cord. This process required only 1.6 seconds and was scalable to human spinal cord sizes and lesion geometries. In this regard, four-centimeter-sized implants modeled from MRI scans of actual human spinal cord injuries were printed within 10 minutes. The printed scaffolds contained dozens of 200-micrometer-wide channels that guided neural stem cell and axon growth along the length of the spinal cord injury.

The investigators tested the ability of MuCPP three-dimensional-printed scaffolds loaded with neural progenitor cells (NPCs) to support axon regeneration and form new "neural relays" across sites of complete spinal cord injury in vivo in rodents.

They reported in the January 14, 2019, online edition of the journal Nature Medicine that injured host axons regenerated into three-dimensional biomimetic scaffolds and synapsed onto NPCs implanted into the device. Implanted NPCs in turn extended axons out of the scaffold and into the host spinal cord below the injury to restore synaptic transmission and significantly improve the animal's ability to move.

"In recent years and papers, we have progressively moved closer to the goal of abundant, long-distance regeneration of injured axons in spinal cord injury, which is fundamental to any true restoration of physical function," said senior author Dr. Mark Tuszynski, professor of neuroscience at the University of California, San Diego.

Related Links:
University of California, San Diego


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.